Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Congressional Dems Generating Heat, But No Hearings, On Rx Prices

This article was originally published in The Pink Sheet Daily

Executive Summary

House oversight committee Democrats want to subpoena Valeant Pharmaceuticals and hold a hearing with Turing Pharmaceuticals on drug price increases. Their requests may have more impact on investors than committee leadership, as the company saw a same-day stock decrease of 16%.

Advertisement

Related Content

Senate's Bipartisan Rx Pricing Probe Seeks Documents Regarding FDA Regs
HHS Raises Profile In Drug Costs Discussion
PhRMA Takes Aim At Valeant In Defense Of Drug Pricing By ‘Innovative’ Firms
The Campaign Against Drug Pricing: Candidates Can Only Hope Voters React As Strongly As Wall Street
Washington Threatens; Wall Street Reacts

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel